Suppr超能文献

抑瘤素M与受体(OSM-OSMR)相互作用的分子模拟作为炎症性肠病的潜在治疗靶点

Molecular Simulation of Oncostatin M and Receptor (OSM-OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease.

作者信息

Du Qingqing, Qian Yan, Xue Weiwei

机构信息

Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, Chongqing, China.

出版信息

Front Mol Biosci. 2020 Mar 4;7:29. doi: 10.3389/fmolb.2020.00029. eCollection 2020.

Abstract

Therapeutics targeting cytokines such as the oncostatin M (OSM)-mediated inflammation represent a potential strategy for the treatment of inflammatory bowel disease (IBD). Despite the investigation of the specific role of the interactions between OSM and the receptor (OSMR) in IBD pathogenesis, the 3D structure of the OSM-OSMR complex remains elusive. In this work, the interaction mode between OSM and OSMR at atomic level was predicted by computational simulation approach. The interaction domain of the OSMR was built with the homology modeling method. The near-native structure of the OSM-OSMR complex was obtained by docking, and long-time scale molecular dynamics (MD) simulation in an explicit solvent was further performed to sample the conformations when OSM binds to the OSMR. After getting the equilibrated states of the simulation system, per-residue energy contribution was calculated to characterize the important residues for the OSM-OSMR complex formation. Based on these important residues, eight residues (OSM: Arg100, Leu103, Phe160, and Gln161; OSMR: Tyr214, Ser223, Asp262, and Trp267) were identified as the "hot spots" through computational alanine mutagenesis analysis and verified by additional MD simulation of R100A (one of the identified "hotspots") mutant. Moreover, six cavities were detected at the OSM-OSMR interface through the FTMap analysis, and they were suggested as important binding sites. The predicted 3D structure of the OSM-OSMR complex and the identified "hot spots" constituting the core of the binding interface provide helpful information in understanding the OSM-OSMR interactions, and the detected sites serve as promising targets in designing small molecules to block the interactions.

摘要

靶向细胞因子(如抑瘤素M(OSM)介导的炎症)的疗法是治疗炎症性肠病(IBD)的一种潜在策略。尽管对OSM与受体(OSMR)之间相互作用在IBD发病机制中的具体作用进行了研究,但OSM - OSMR复合物的三维结构仍不清楚。在这项工作中,通过计算模拟方法预测了OSM与OSMR在原子水平上的相互作用模式。采用同源建模方法构建了OSMR的相互作用结构域。通过对接获得了OSM - OSMR复合物的近天然结构,并在显式溶剂中进行了长时间尺度的分子动力学(MD)模拟,以对OSM与OSMR结合时的构象进行采样。在获得模拟系统的平衡态后,计算每个残基的能量贡献以表征形成OSM - OSMR复合物的重要残基。基于这些重要残基,通过计算丙氨酸诱变分析确定了八个残基(OSM:Arg100、Leu103、Phe160和Gln161;OSMR:Tyr214、Ser223、Asp262和Trp267)为“热点”,并通过对R100A(已鉴定的“热点”之一)突变体的额外MD模拟进行了验证。此外,通过FTMap分析在OSM - OSMR界面检测到六个空腔,它们被认为是重要的结合位点。预测的OSM - OSMR复合物三维结构以及构成结合界面核心的已鉴定“热点”为理解OSM - OSMR相互作用提供了有用信息,并且检测到的位点有望成为设计小分子以阻断相互作用的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/7064634/bd603e788db4/fmolb-07-00029-g0001.jpg

相似文献

2
Unbiased molecular dynamics simulation of a first-in-class small molecule inhibitor binds to oncostatin M.
Comput Biol Med. 2023 Mar;155:106709. doi: 10.1016/j.compbiomed.2023.106709. Epub 2023 Feb 23.
3
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts.
Inflamm Bowel Dis. 2024 Nov 4;30(11):2162-2173. doi: 10.1093/ibd/izae098.
4
The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
J Biol Chem. 2018 Dec 28;293(52):20181-20199. doi: 10.1074/jbc.RA118.004375. Epub 2018 Oct 29.
5
Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Cytokine. 2014 Aug;68(2):101-9. doi: 10.1016/j.cyto.2014.04.001. Epub 2014 Apr 22.
6
Cross-reactivity of two human IL-6 family cytokines OSM and LIF explored by protein-protein docking and molecular dynamics simulation.
Biochim Biophys Acta Gen Subj. 2021 Jul;1865(7):129907. doi: 10.1016/j.bbagen.2021.129907. Epub 2021 Apr 9.
7
Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort.
J Pediatr Gastroenterol Nutr. 2021 Sep 1;73(3):352-357. doi: 10.1097/MPG.0000000000003201.
8
Oncostatin M and its receptors mRNA regulation in bovine granulosa and luteal cells.
Theriogenology. 2019 Feb;125:324-330. doi: 10.1016/j.theriogenology.2018.11.021. Epub 2018 Nov 22.

引用本文的文献

1
Development of the First Small-Molecule Inhibitor Targeting Oncostatin M for Treatment of Breast Cancer.
J Med Chem. 2025 Aug 14;68(15):15422-15445. doi: 10.1021/acs.jmedchem.4c03233. Epub 2025 Aug 1.
2
The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review.
Open Life Sci. 2024 Dec 31;19(1):20221023. doi: 10.1515/biol-2022-1023. eCollection 2024.
3
Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes.
Nat Commun. 2024 Nov 12;15(1):9776. doi: 10.1038/s41467-024-54124-1.
4
Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis.
Front Immunol. 2023 Nov 1;14:1258765. doi: 10.3389/fimmu.2023.1258765. eCollection 2023.
5
Transcriptomic Analysis of THP-1 Cells Exposed by Monosodium Urate Reveals Key Genes Involved in Gout.
Comb Chem High Throughput Screen. 2024;27(18):2741-2752. doi: 10.2174/0113862073262471231011043339.
6
The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
Front Immunol. 2023 Sep 29;14:1239732. doi: 10.3389/fimmu.2023.1239732. eCollection 2023.
8
Computational Protein Design - Where it goes?
Curr Med Chem. 2024;31(20):2841-2854. doi: 10.2174/0929867330666230602143700.
10
Modern drug discovery for inflammatory bowel disease: The role of computational methods.
World J Gastroenterol. 2023 Jan 14;29(2):310-331. doi: 10.3748/wjg.v29.i2.310.

本文引用的文献

1
Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD).
Expert Opin Ther Targets. 2019 Nov;23(11):943-954. doi: 10.1080/14728222.2019.1677608. Epub 2019 Oct 15.
2
End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design.
Chem Rev. 2019 Aug 28;119(16):9478-9508. doi: 10.1021/acs.chemrev.9b00055. Epub 2019 Jun 24.
4
Elucidating the tight-binding mechanism of two oral anticoagulants to factor Xa by using induced-fit docking and molecular dynamics simulation.
J Biomol Struct Dyn. 2020 Feb;38(2):625-633. doi: 10.1080/07391102.2019.1583605. Epub 2019 Apr 9.
5
Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
Gastric Cancer. 2019 Sep;22(5):955-966. doi: 10.1007/s10120-019-00934-y. Epub 2019 Feb 18.
6
Calculation of hot spots for protein-protein interaction in p53/PMI-MDM2/MDMX complexes.
J Comput Chem. 2019 Apr 5;40(9):1045-1056. doi: 10.1002/jcc.25592. Epub 2018 Dec 14.
8
The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
J Biol Chem. 2018 Dec 28;293(52):20181-20199. doi: 10.1074/jbc.RA118.004375. Epub 2018 Oct 29.
10
The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
J Biol Chem. 2018 May 4;293(18):7017-7029. doi: 10.1074/jbc.RA118.001920. Epub 2018 Mar 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验